KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent TaxesDividends payablesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtOther Accumulated ExpensesPayablesPensionPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Abbott Laboratories (ABT) Common Equity (2016 - 2025)

Historic Common Equity for Abbott Laboratories (ABT) over the last 17 years, with Q3 2025 value amounting to $51.3 billion.

  • Abbott Laboratories' Common Equity rose 2807.04% to $51.3 billion in Q3 2025 from the same period last year, while for Sep 2025 it was $51.3 billion, marking a year-over-year increase of 2807.04%. This contributed to the annual value of $47.9 billion for FY2024, which is 2337.03% up from last year.
  • As of Q3 2025, Abbott Laboratories' Common Equity stood at $51.3 billion, which was up 2807.04% from $50.8 billion recorded in Q2 2025.
  • In the past 5 years, Abbott Laboratories' Common Equity registered a high of $51.3 billion during Q3 2025, and its lowest value of $31.5 billion during Q4 2021.
  • Moreover, its 5-year median value for Common Equity was $37.4 billion (2023), whereas its average is $39.3 billion.
  • In the last 5 years, Abbott Laboratories' Common Equity surged by 187.38% in 2023 and then surged by 2848.58% in 2025.
  • Quarter analysis of 5 years shows Abbott Laboratories' Common Equity stood at $31.5 billion in 2021, then rose by 11.83% to $35.3 billion in 2022, then grew by 10.13% to $38.8 billion in 2023, then grew by 23.37% to $47.9 billion in 2024, then rose by 7.02% to $51.3 billion in 2025.
  • Its Common Equity was $51.3 billion in Q3 2025, compared to $50.8 billion in Q2 2025 and $49.1 billion in Q1 2025.